30086-49-8

Basic information

• Product Name: 2-Amino-N'-phenylbenzohydrazide
• Synonyms: 2-Amino-N'-phenylbenzohydrazide
• CAS NO: 30086-49-8
• Molecular Formula: C₁₃H₁₃N₃O
• Molecular Weight: 227
• Mol File: 30086-49-8.mol
• Article Data: 18

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2-Amino-N'-phenylbenzohydrazide(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Amino-N'-phenylbenzohydrazide(30086-49-8)
• EPA Substance Registry System: 2-Amino-N'-phenylbenzohydrazide(30086-49-8)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 30086-49-8(Hazardous Substances Data)

Usage

General Description

2-Amino-N'-phenylbenzohydrazide is a chemical compound with the molecular formula C13H12N4O. It is a hydrazide derivative, which is a class of organic compounds containing a functional group with the structure HN-NH-CO-R. 2-Amino-N'-phenylbenzohydrazide is commonly used as a reagent in organic synthesis and pharmaceutical research. It has been studied for its potential antitumor and anti-inflammatory properties, and has also been used in the development of new drugs due to its ability to inhibit certain enzymes. Additionally, 2-Amino-N'-phenylbenzohydrazide has been investigated for its potential use in the treatment of neurodegenerative diseases. Overall, this chemical compound has shown promising biological activities and has potential applications in various fields.

Upstream product

• 75681-27-5 N'-phenyl-2-nitrobenzoylhydrazine 
• 100-63-0 phenylhydrazine 
• 610-14-0 2-nitrobenzyl chloride 
• 118-92-3 anthranilic acid 
• 118-48-9 isatoic anhydride 
• 64-17-5 ethanol 

Downstream Products

• 5958-14-5 3-anilino-2-thiotetrahydroquinazole-4-one  
• 67571-01-1 4a-methyl-1-phenyl-3,4,4a,5-tetrahydro-pyridazino[3,2-b]quinazoline-2,10-dione 
• 1137183-11-9 1-phenyl-3,4-dihydro-1H-pyridazino[6,1-b]quinazoline-2,10-dione 
• 1137183-04-0 2-[(2-carboxybenzoyl)amino]-2-N-phenylbenzohydrazide 
• 1370643-32-5 5-phenylindazolo[3,2-b]quinazolin-7(5H)-one 
• 1437780-30-7 2-fluoro-5-phenylindazolo[3,2-b]quinazolin-7(5H)-one 
• 1437780-31-8 3-fluoro-5-phenylindazolo[3,2-b]quinazolin-7(5H)-one 
• 1437780-32-9 2-methoxy-5-phenylindazolo[3,2-b]quinazolin-7(5H)-one 
• 1437780-33-0 2-chloro-5-phenylindazolo[3,2-b]quinazolin-7(5H)-one 
• 1437780-34-1 2,3-dimethoxy-5-phenylindazolo[3,2-b]quinazolin-7(5H)-one 
• 1437780-35-2 5-phenyl-[1,3]dioxolo[4′,5′:5,6]indazolo[3,2-b]quinazolin-7(5H)-one 
• 1437780-38-5 1-chloro-5-phenylindazolo[3,2-b]quinazolin-7(5H)-one 
• 26032-23-5 2-(2-hydroxyphenyl)-3-(phenylamino)-2,3-dihydroquinazolin-4(1H)-one 
• 1469886-60-9 13-iodo-12-(cyclohexen-1-yl)-5-(phenylamino)-4bH-isoquinolino[2,1-a]quinazolin-6(5H)-one 

Relevant articles and documents

Synthesis of quaternary carbon-centered indolo[1,2-a]quinazolinones and indazolo[1,2-a]indazolonesviaC-H functionalization

An unprecedented Ru(ii)-catalyzed Csp2-H bond activation and annulation reaction of phenylindazolones with diaryl-substituted alkynes and dialkyl-substituted alkynes provided efficient routes for the construction of all-carbon quaternary-centered indolo[1,2-a]quinazolinones and quaternary carbon-centered indazolo[1,2-a]indazolones, respectively. The indolo[1,2-a]quinazolinones were fomedviaCsp2-H activation, alkyne insertion and a 1,2-phenyl shift. Indazolo[1,2-a]indazolones were formed through a cascade reactionviathe formation of exocyclic double bonds containing indolo[1,2-a]quinazolinones.

Synthesis and anti-microbial / anti-malarial activity of a new class of chromone-dihydroquinazolinone hybrid heterocycles

A new series of chromone-2,3-dihydroquinazolin-4-one hybrid heterocycles are synthesized from chromone-2-carbaldehydes by coupling with 2-Aminoarylamides and hydrazides without oxidizing agents. The newly synthesized products exhibited moderate to good antimicrobial activity.

Anti-tumor pyrimidine compounds and preparation method thereof

The invention belongs to the field of medicines and particularly relates to anti-tumor pyrimidine compounds and a preparation method thereof. The compounds belong to novel VEGFR (vascular endothelial growth factor receptor)-2 inhibitors and show good inhi